Market Place
Sourcing Support
Guardant Reveal Backed by Largest Stage III Colon Cancer MRD
02 Feb 2026 //
BUSINESSWIRE
Guardant Health to Report Q4, FY 2025 Results Feb. 19
29 Jan 2026 //
BUSINESSWIRE
Guardant Health Gets FDA Nod For Guardant360 CDx With BRAFTOVI
22 Jan 2026 //
BUSINESSWIRE
Guardant Health, Merck Partner To Develop Cancer Therapies
19 Jan 2026 //
BUSINESSWIRE
Guardant Health Reveals 2025 Q4 And Full-Year Results
11 Jan 2026 //
BUSINESSWIRE
Guardant Health Launches Shield Blood Test For Colorectal Cancer
08 Jan 2026 //
BUSINESSWIRE
Guardant Health Joins 44Th J.P. Morgan Healthcare Conference
29 Dec 2025 //
BUSINESSWIRE
Global Healthy Living & Guardant Health Announce Partnership
29 Dec 2025 //
BUSINESSWIRE
Guardant Health, Trial Library Partner to Boost U.S. Cancer
11 Dec 2025 //
BUSINESSWIRE
Guardant Health, Policlinico Gemelli Launch Liquid Biopsy
09 Dec 2025 //
PHARMIWEB
Guardant Health Showcases Multiomic Liquid Biopsy Impact
05 Dec 2025 //
BUSINESSWIRE
Guardant Health Expands Reveal Test For Late-Stage Therapy
10 Nov 2025 //
BUSINESS WIRE
Guardant Health To Participate In Upcoming Investor Conferences
07 Nov 2025 //
BUSINESSWIRE
Guardant Reveal Blood Test Validated For Chemotherapy Response
06 Nov 2025 //
BUSINESS WIRE
Guardant Health Reveals Inducement Grants Per Nasdaq LR
06 Nov 2025 //
BUSINESSWIRE
Guardant Health Prices $350M Convertible Senior Notes Offering
05 Nov 2025 //
BUSINESSWIRE
Shield CRC Blood Test Shows 95% Adherence In 20K-Patient Study
05 Nov 2025 //
BUSINESSWIRE
Guardant Health Prices Increased Public Stock Offering
05 Nov 2025 //
BUSINESSWIRE
Guardant Health Plans $300M Convertible Senior Notes Offering
04 Nov 2025 //
BUSINESSWIRE
Guardant Health Announces Proposed Public Offering of Stock
04 Nov 2025 //
BUSINESSWIRE
Guardant Health Boosts 2025 Revenue Forecast After Q3 Financials
29 Oct 2025 //
BUSINESSWIRE
Guardant Health, ZephyrAI Partner To Unlock Drug Response
27 Oct 2025 //
BUSINESS WIRE
Guardant Health To Present Blood-Based Testing Impact On Cancer
26 Oct 2025 //
BUSINESSWIRE
Guardant Health, Collaborators To Unveil Cancer Care Data
15 Oct 2025 //
BUSINESSWIRE
Guardant Health To Release Q3 2025 Financial Results On October
09 Oct 2025 //
BUSINESSWIRE
FDA Approves Guardant360® Cdx For Eli Lilly`s Inluriyo
29 Sep 2025 //
BUSINESSWIRE
Guardant Backs ALA`s Lung Cancer Testing Awareness Drive
25 Sep 2025 //
FIERCE PHARMA
Guardant, Quest Partner To Expand Shield Blood Screening In US
24 Sep 2025 //
BUSINESSWIRE
Alex M. Azar II Appointed to Guardant Health Board
15 Sep 2025 //
BUSINESSWIRE
Guardant, LabFlorida Partner to Offer Shield CRC Test to Seniors
11 Sep 2025 //
BUSINESSWIRE
Guardant, PathGroup Partner to Bring Shield Blood Test
08 Sep 2025 //
BUSINESSWIRE
Guardant Health Updates Clinical Data on Colorectal Cancer Test
04 Sep 2025 //
BUSINESSWIRE
Guardant Health to Host Investor Day on September 24, 2025
28 Aug 2025 //
BUSINESSWIRE
Guardant Health to Present at Morgan Stanley Global Confernece
26 Aug 2025 //
BUSINESSWIRE
Guardant Health Announces Inducement Grants Under Rule 5635(c)(4)
15 Aug 2025 //
BUSINESSWIRE
Guardant Health to Join Canaccord Genuity 45th Growth Conference
31 Jul 2025 //
BUSINESSWIRE
Guardant Health Raises 2025 Guidance, Shares Q2 Update
30 Jul 2025 //
BUSINESSWIRE
Guardant and Van Der Beek Promote Colon Cancer Blood Test
30 Jul 2025 //
FIERCE PHARMA
Vanguard Starts Study on Guardant`s Shield Cancer Detection Test
15 Jul 2025 //
BUSINESSWIRE
Guardant Health to Report Q2 2025 Financial Results on July 30
14 Jul 2025 //
BUSINESSWIRE
Bay Area Lyme Foundation Announces New Executive Director Wein
18 Jun 2025 //
GLOBENEWSWIRE
Guardant Health Wins Fast Company’s 2025 World Changing Ideas Awa
10 Jun 2025 //
BUSINESSWIRE
ESMO Open study shows Guardant Reveal`s performance in detecting
09 Jun 2025 //
BUSINESSWIRE
Guardant360-Guided Breast Cancer Therapy Swaps Boost Survival
03 Jun 2025 //
FIERCE BIOTECH
SERENA-6 Trial Shows Guardant360 CDx Test Value in Breast Cancer
02 Jun 2025 //
BUSINESSWIRE
NCCN Adds Shield Blood Test To Colorectal Cancer Guidelines
02 Jun 2025 //
BUSINESSWIRE
Guardant Reveals MRD study in Colon Cancer for Treatment Decision
31 May 2025 //
BUSINESSWIRE
Guardant Adds Smart Liquid Biopsy Apps for Guardant360
27 May 2025 //
BUSINESSWIRE
Guardant Health, Collaborators to Present 19 Studies at 2025 ASCO
22 May 2025 //
BUSINESSWIRE
Guardant Health Introduces Immunohistochemistry Testing for Tumor
21 May 2025 //
BUSINESSWIRE
Guardant Health Introduces Hereditary Cancer Testing
20 May 2025 //
BUSINESSWIRE
TIME Names Guardant Health Co-CEOs to 2025 TIME100 Health List
08 May 2025 //
BUSINESSWIRE
Guardant Health to Participate in Upcoming Investor Conferences
08 May 2025 //
BUSINESSWIRE
Guardant Health Announces Inducement Grants Under Nasdaq Listing
07 May 2025 //
BUSINESSWIRE
Guardant Health Reports Q1 2025 Results, 2025 Revenue Guidance
30 Apr 2025 //
BUSINESSWIRE
Guardant Health Shows Shield Test Performance Across 10 Tumors
29 Apr 2025 //
BUSINESSWIRE
Guardant Health Launches Guardant360 Tissue for Cancer Profiling
28 Apr 2025 //
BUSINESSWIRE
Guardant Health, Pfizer collaborate on Cancer Therapies
24 Apr 2025 //
BUSINESSWIRE
Guardant Health to Present Advances in Multi-Cancer Detection
22 Apr 2025 //
BUSINESSWIRE
Guardant Health to Report Q1 2025 Financial Results on April 30
10 Apr 2025 //
BUSINESSWIRE
